{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:25:55Z","timestamp":1793676355997,"version":"4.5.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00259-026-08110-y","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:30:50Z","timestamp":1789371050000},"page":"8582-8596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of 68Ga-PSMA-11 PET\/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1562-3871","authenticated-orcid":false,"given":"L.","family":"Vetrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vasuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Degiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Renzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cattabriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Malizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ravaioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cescon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"5","key":"8110_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep4.1861","volume":"6","author":"SM Thompson","year":"2022","unstructured":"Thompson SM, Suman G, Torbenson MS, et al. PSMA as a theranostic target in hepatocellular carcinoma: immunohistochemistry and 68 Ga-PSMA-11 PET using cyclotron-produced 68 Ga. Hepatol Commun. 2022;6(5):1172\u201385.","journal-title":"Hepatol Commun"},{"issue":"9","key":"8110_CR2","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2967\/jnumed.120.257915","volume":"68","author":"N Hirmas","year":"2021","unstructured":"Hirmas N, Leyh C, Sraieb M, et al. Ga-PSMA-11 PET\/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma. J Nucl Med. 2021;68(9):1235\u201341.","journal-title":"J Nucl Med"},{"issue":"2","key":"8110_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL Clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82(2):315\u201374.","journal-title":"J Hepatol"},{"issue":"3","key":"8110_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681\u201393.","journal-title":"J Hepatol"},{"issue":"2","key":"8110_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/radiol.2021211244","volume":"302","author":"CB van der Pol","year":"2022","unstructured":"van der Pol CB, McInnes MDF, Salameh JP, et al. CT\/MRI and CEUS LI-RADs major features association with hepatocellular carcinoma: individual patient data meta-analysis. Radiology. 2022;302(2):326\u201335.","journal-title":"Radiology"},{"issue":"2","key":"8110_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, Gandaglia G, Gillessen S, Grivas N, Henry AM, Lardas M, van Leenders GJLH, Liew M, Linares Espinos E, Oldenburg J, van Oort IM, Oprea-Lager DE, Ploussard G, Roberts MJ, Rouvi\u00e8re O, Schoots IG, Schouten N, Smith EJ, Stranne J, Wiegel T, Willemse PM, Tilki D. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"issue":"6","key":"8110_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/aor.14715","volume":"48","author":"G Dajti","year":"2024","unstructured":"Dajti G, Germinario G, Prosperi E, et al. The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation. Artif Organs. 2024;48(6):619\u201325.","journal-title":"Artif Organs"},{"issue":"10","key":"8110_CR8","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.3390\/cancers13102398","volume":"13","author":"M Serenari","year":"2021","unstructured":"Serenari M, Prosperi E, Allard MA. at al. The Impact of time interval between hepatic resection and liver transplantation on clinical outcome in patients with hepatocellular carcinoma. Cancers (Basel). 2021;13(10):2398.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"8110_CR9","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/cancers15061716","volume":"15","author":"L Vetrone","year":"2023","unstructured":"Vetrone L, Mei R, Bianchi L, et al. Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET\/CT Features in Primary Staging. Cancers (Basel). 2023;15(6):1716.","journal-title":"Cancers (Basel)"},{"key":"8110_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"29","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol. 2014;29:9:221.","journal-title":"Diagn Pathol"},{"issue":"2","key":"8110_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4274\/mirt.galenos.2021.92053","volume":"30","author":"C G\u00fcndo\u011fan","year":"2021","unstructured":"G\u00fcndo\u011fan C, Erg\u00fcl N, \u00c7ak\u0131r MS, et al. 68Ga-PSMA PET\/CT Versus 18F-FDG PET\/CT for Imaging of Hepatocellular Carcinoma. Mol Imaging Radionucl Ther. 2021;30(2):79\u201385.","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"22","key":"8110_CR12","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.3390\/cancers16223865","volume":"16","author":"N Hannah","year":"2024","unstructured":"Hannah N, Yu C, Nedumannil L, et al. Prostate-Specific Membrane Antigen (PSMA) PET\/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis. Cancers (Basel). 2024;16(22):3865.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8110_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/tomography9010011","volume":"9","author":"VCK Wong","year":"2023","unstructured":"Wong VCK, Yip J, Fragomeli V, et al. Comparison between PSMA PET\/CT and MRI for Characterizing Hepatocellular carcinoma: A Real-World Study. Tomography. 2023;9(1):130\u20138.","journal-title":"Tomography"},{"issue":"21","key":"8110_CR14","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.3390\/jcm11216590","volume":"11","author":"C Lauri","year":"2022","unstructured":"Lauri C, Chiurchioni L, Russo VM, et al. PSMA expression in solid tumors beyond the prostate gland: ready for theranostic applications? J Clin Med. 2022;11(21):6590.","journal-title":"J Clin Med"},{"issue":"5","key":"8110_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","volume":"10","author":"D Jiao","year":"2019","unstructured":"Jiao D, Li Y, Yang F, et al. Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(5):1\u20137.","journal-title":"Clin Transl Gastroenterol"},{"issue":"48","key":"8110_CR16","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.3748\/wjg.v26.i48.7664","volume":"26","author":"LX Chen","year":"2020","unstructured":"Chen LX, Zou SJ, Li D, et al. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol. 2020;26(48):7664\u201378.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"8110_CR17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/ph15111368","volume":"15","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Racca M, Albano D, Dondi F, Bertagna F, Annunziata S, Treglia G. Can PSMA-targeting radiopharmaceuticals be useful for detecting hepatocellular carcinoma using positron emission tomography? An updated systematic review and meta-analysis. Pharmaceuticals. 2022;15(11):1368. https:\/\/doi.org\/10.3390\/ph15111368","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"8110_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00259-020-05017-0","volume":"48","author":"J Kunikowska","year":"2021","unstructured":"Kunikowska J, Cie\u015blak B, Gierej B, Patkowski W, Kraj L, Kotulski M, Zieniewicz K, Kr\u00f3licki L. [68 Ga]Ga-Prostate-Specific Membrane Antigen PET\/CT: a novel method for imaging patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(3):883\u201392. https:\/\/doi.org\/10.1007\/s00259-020-05017-0","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08110-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:31Z","timestamp":1793672971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":18,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8110"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08110-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Ethics Committee (n. 538\/2021\/Oss\/AUBO) and registered on ClinicalTrial.gov (NCT06835244).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for the publication of images was received from the participant who appeared in the manuscript.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}